Trade Summary

2 days ago, Veness Adam M, serving as SVP, General Counsel and Sec. at Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 30,000 shares at $80.80 per share, for a total transaction value of $2,423,958.16.

This sale represents a 100.00% decrease in Veness Adam M's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, June 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 18, 2026 at 4:30 PM ET, 1 day after the trade was made.

Dianthus Therapeutics, Inc. /DE/ operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.